Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis

Experimental Eye Research

Volumn 87, Issue 5, 2008, Pages 427-432

  Hos, D ^a   Bachmann, B ^a   Bock, F ^a   Onderka, J ^a   Cursiefen, C ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

corneal transplantation; high risk keratoplasty; lymphangiogenesis; neovascularization

Indexed keywords

CELL MARKER; PROTEIN LYVE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; KERATITIS; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

AGING; ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; KERATITIS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 54249170444     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.07.013     Document Type: Article

References (24)

1. Bock F., et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Investig. Ophthalmol. Vis. Sci. 48 (2007) 2545-2552
2. Bock F., et al. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp. Eye Res. 87 (2008) 462-470
3. Boisjoly H.M., et al. Risk factors of corneal graft failure. Ophthalmology 100 (1993) 1728-1735
4. Cursiefen C., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004) 1040-1050
5. Cursiefen C., et al. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22 (2003) 273-281
6. Cursiefen C., et al. Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea 17 (1998) 611-613
7. Cursiefen C., et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Investig. Ophthalmol. Vis. Sci. 43 (2002) 2127-2135
8. Cursiefen C., et al. Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefe's Arch. Clin. Exp. Ophthalmol. 239 (2001) 514-521
9. Dana M.R., et al. Corneal neovascularization after penetrating keratoplasty. Cornea 14 (1995) 604-609
10. Dana M.R., and Streilein J.W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Investig. Ophthalmol. Vis. Sci. 37 (1996) 2485-2494
11. Dietrich T., et al. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am. J. Pathol. 171 (2007) 361-372
12. Erusalimsky J.D., and Kurz D.J. Endothelial cell senescence. Handb. Exp. Pharmacol. (2006) 213-248
13. Hos D., et al. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Investig. Ophthalmol. Vis. Sci. 49 (2008) 1836-1842
14. Liu Y., et al. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J. Exp. Med. 195 (2002) 259-268
15. Maguire M.G., et al., Collaborative Corneal Transplantation Studies Research Group. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 101 (1994) 1536-1547
16. Minamino T., et al. Vascular cell senescence and vascular aging. J. Mol. Cell Cardiol. 36 (2004) 175-183
17. Panda A., et al. Corneal graft rejection. Surv. Ophthalmol. 52 (2007) 375-396
18. Reed M.J., et al. Neovascularization in aged mice: delayed angiogenesis is coincident with decreased levels of transforming growth factor beta1 and type I collagen. Am. J. Pathol. 152 (1998) 113-123
19. Rivard A., et al. Age-dependent impairment of angiogenesis. Circulation 99 (1999) 111-120
20. Sadoun E., and Reed M.J. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J. Histochem. Cytochem. 51 (2003) 1119-1130
21. Sano Y., et al. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Investig. Ophthalmol. Vis. Sci. 36 (1995) 2176-2185
22. Sonoda Y., and Streilein J.W. Orthotopic corneal transplantation in mice - evidence that the immunogenetic rules of rejection do not apply. Transplantation 54 (1992) 694-704
23. Swift M.E., et al. Impaired wound repair and delayed angiogenesis in aged mice. Lab. Invest. 79 (1999) 1479-1487
24. Yamaura H., and Matsuzawa T. Decrease in capillary growth during aging. Exp. Gerontol. 15 (1980) 145-150